On June 10, we participated in the DCAT (Drug, Chemical & Associated Technologies Association) #GlobalSummit in Barcelona, an event that brings together global leaders from the biopharmaceutical sector to discuss the impact of technology on the industry.

At the event, we partnered with mAbxience to present a success story showcasing the application of artificial intelligence in industrial settings: a digital twin for biopharmaceutical manufacturing.

Félix Fernández Romero, alongside Timo Liebig (CIO of mAbxience), shared how this solution enables the replication of production processes to anticipate outcomes, optimize operations, and improve decision-making.

This project perfectly reflects our goal of improving the future of work: we approach AI from a practical standpoint, solving real-world problems and adapting it to the needs of each sector.

We would like to thank DCAT for creating a space where technology, industry, and talent can come together.